In another approach, an antagonistic modified RNA oligonucleotide (antagomiR), which selectively targets the BMPR2 negative regulator miR-20a, increased levels of BMPRII expression in lung tissue and improved cardiopulmonary parameters in a hypoxia-induced mouse model of PAH (113). The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.